At the end of the inspection, no observation (483) is issued.
The US Food and Drug Administration (USFDA) inspected the company's formulations manufacturing facility located at Baddi (Himachal Pradesh) from 2nd to 9th March 2020. This was a Current Good Manufacturing Practice (cGMP) and post approval inspection. At the end of the inspection, no observation (483) is issued, the company said in a statement on Monday, 9 March 2020.Cadila Healthcare is a pharmaceutical company based in India. On a consolidated basis, the drug maker's net profit fell 26.5% to Rs 375.18 crore on a 0.5% increase in net sales to Rs 3,534.50 crore in Q3 December 2019 Q3 December 2018.
Shares of Cadila Healthcare were down 3.38% at Rs 257.20. Meanwhile, the benchmark BSE Sensex tanked 1830.65 points or 4.87% to 35,745.97 amid global selloff.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app